ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
16.77
-0.31 (-1.79%)
Mar 31, 2025, 10:01 AM EDT - Market open
ACADIA Pharmaceuticals Employees
As of December 31, 2024, ACADIA Pharmaceuticals had 654 total employees, including 653 full-time and 1 part-time employees. The number of employees increased by 56 or 9.36% compared to the previous year.
Employees
654
Change (1Y)
56
Growth (1Y)
9.36%
Revenue / Employee
$1,464,521
Profits / Employee
$346,255
Market Cap
2.80B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ACAD News
- 16 days ago - Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 17 days ago - Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences - Business Wire
- 25 days ago - Clinical Data from Open-Label DAFFODIL™ Study Evaluating Long-term Safety of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Med - Business Wire
- 27 days ago - Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study - Business Wire
- 4 weeks ago - Acadia Pharmaceuticals Ends FY2024 On Solid Footing - Seeking Alpha
- 4 weeks ago - Acadia Pharmaceuticals to Participate in the TD Cowen's 45th Annual Health Care Conference - Business Wire
- 4 weeks ago - ACADIA Pharmaceuticals Inc. (ACAD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operating Overview - Business Wire